These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation. Bitterman PB; Polunovsky VA Mol Cancer Ther; 2012 May; 11(5):1051-61. PubMed ID: 22572598 [TBL] [Abstract][Full Text] [Related]
3. Targeting the eIF4F translation initiation complex for cancer therapy. Konicek BW; Dumstorf CA; Graff JR Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377 [TBL] [Abstract][Full Text] [Related]
4. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Bitterman PB; Polunovsky VA Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766 [TBL] [Abstract][Full Text] [Related]
5. c-Myc and eIF4F constitute a feedforward loop that regulates cell growth: implications for anticancer therapy. Lin CJ; Malina A; Pelletier J Cancer Res; 2009 Oct; 69(19):7491-4. PubMed ID: 19773439 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of eIF-4E positively regulates formation of the eIF-4F translation initiation complex following DNA damage. Zhang Y; Li Y; Yang DQ Biochem Biophys Res Commun; 2008 Feb; 367(1):54-9. PubMed ID: 18164262 [TBL] [Abstract][Full Text] [Related]
8. Targeting the eIF4F translation initiation complex: a critical nexus for cancer development. Pelletier J; Graff J; Ruggero D; Sonenberg N Cancer Res; 2015 Jan; 75(2):250-63. PubMed ID: 25593033 [TBL] [Abstract][Full Text] [Related]
9. Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment. Malka-Mahieu H; Newman M; Désaubry L; Robert C; Vagner S Clin Cancer Res; 2017 Jan; 23(1):21-25. PubMed ID: 27789529 [TBL] [Abstract][Full Text] [Related]
10. Drug development: a chance of survival. Hoag H Nature; 2014 Nov; 515(7527):S118-20. PubMed ID: 25407709 [No Abstract] [Full Text] [Related]
11. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. Cencic R; Hall DR; Robert F; Du Y; Min J; Li L; Qui M; Lewis I; Kurtkaya S; Dingledine R; Fu H; Kozakov D; Vajda S; Pelletier J Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1046-51. PubMed ID: 21191102 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity to anti-BRAF therapy: lost in translation. Kalkavan H; Goding CR Pigment Cell Melanoma Res; 2015 Jan; 28(1):4-5. PubMed ID: 25220342 [No Abstract] [Full Text] [Related]
13. Tumor suppression by small molecule inhibitors of translation initiation. Chen L; Aktas BH; Wang Y; He X; Sahoo R; Zhang N; Denoyelle S; Kabha E; Yang H; Freedman RY; Supko JG; Chorev M; Wagner G; Halperin JA Oncotarget; 2012 Aug; 3(8):869-81. PubMed ID: 22935625 [TBL] [Abstract][Full Text] [Related]
15. A novel interaction of Cap-binding protein complexes eukaryotic initiation factor (eIF) 4F and eIF(iso)4F with a region in the 3'-untranslated region of satellite tobacco necrosis virus. Gazo BM; Murphy P; Gatchel JR; Browning KS J Biol Chem; 2004 Apr; 279(14):13584-92. PubMed ID: 14729906 [TBL] [Abstract][Full Text] [Related]
16. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication. Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587 [TBL] [Abstract][Full Text] [Related]
17. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma. Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159 [TBL] [Abstract][Full Text] [Related]
18. Evidence for variation in the optimal translation initiation complex: plant eIF4B, eIF4F, and eIF(iso)4F differentially promote translation of mRNAs. Mayberry LK; Allen ML; Dennis MD; Browning KS Plant Physiol; 2009 Aug; 150(4):1844-54. PubMed ID: 19493973 [TBL] [Abstract][Full Text] [Related]
19. Homogenous time resolved fluorescence assay to identify modulators of cap-dependent translation initiation. Cencic R; Yan Y; Pelletier J Comb Chem High Throughput Screen; 2007 Mar; 10(3):181-8. PubMed ID: 17346117 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of eIF4F complex loading inhibits the survival of malignant glioma. Dong QF; Yan ZF; Li PQ; Yang X; Huo JL; Zhen HN Oncol Rep; 2018 Oct; 40(4):2399-2407. PubMed ID: 30066885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]